tiprankstipranks
Globus Medical price target raised to $87 from $78 at BTIG
The Fly

Globus Medical price target raised to $87 from $78 at BTIG

BTIG raised the firm’s price target on Globus Medical (GMED) to $87 from $78 and keeps a Buy rating on the shares after its Q3 earnings beat and guidance raise. The company is disproving any and all preconceived notions of why spine mergers cannot work, the analyst tells investors in a research note. Globus Medical’s financial discipline and operational execution are also creating a flywheel effect likely to yield significant free cash flow conversion that will ultimately drive share buybacks, the firm added.

Don't Miss Our Christmas Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App